Clinical Trials Sponsored by Renown Health

Total 50433 results

University of Nevada, Reno
Renown Regional Medical Center

Completed

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Clostridium Difficile Infection

United States
Renown Health
Fisher and Paykel Healthcare

Terminated

AIRVO Device Intervention for Moderate to Severe COPD (AIRVO)

COPD | COPD Exacerbation

United States
University of Nevada, Reno
Renown Regional Medical Center

Completed

"SVEAT" Chest Pain Scoring System

Chest Pain

United States
Renown Regional Medical Center

Unknown

FIT Mailing Protocol-For Cancer Screening Navigation

Colorectal Neoplasms

United States
LactaLogics, Inc
Renown Regional Medical Center

Completed

Newborns Supplemented With Gentle-UHT Donor Milk

Newborns | Breast Milk Expression

United States
Renovo

Completed

A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo (RN1006)

Scar Improvement

United Kingdom
Renovo

Withdrawn

Juvista in the Non-surgical Improvement of Existing Scars

Scars

United Kingdom
Renovo

Completed

Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects

Cicatrix | Wound Healing

United Kingdom
Renovo

Terminated

Juvista (Avotermin) in Breast Reduction Surgery Scars

Cicatrix | Mammaplasty

United Kingdom
Renovo

Completed

Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites

Wound

United Kingdom
Renovo

Unknown

A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision

Cicatrix | Nevus

United Kingdom
Renovo

Completed

Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women

Cicatrix

United Kingdom
Renovo

Completed

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

Cicatrix

United Kingdom
Renovo

Completed

Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids

Keloid

United States
Renovo

Completed

Safety of Juvista When Administered Following Excision of Ear Lobe Keloids (RN1001-0093)

Keloid

United States
Renovo

Completed

Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)

Cicatrix | Wound Healing | Re-epithelialization

United Kingdom
Renovo

Completed

Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars

Keloid

United States
Renovo

Completed

Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

Trauma | Burn | Varicose Ulcer

United Kingdom, Russian Federation, Germany, Latvia
Renovo

Completed

Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

Cicatrix

United Kingdom
Renovo

Completed

Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082

Wound

United Kingdom
Renovo

Completed

RN1001(Avotermin) in Scar Improvement Following Breast Augmentation

Cicatrix | Mammaplasty

United Kingdom
Renovo

Completed

Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males

Cicatrix

United Kingdom
Renovo

Completed

Juvista in Scar Revision Surgery of Disfiguring Scars (Revise)

Cicatrix

Spain, France, Hungary, Italy, United Kingdom, United States, Denmark, Germany, Latvia, Poland
Renovo

Unknown

Prevascar in African Continental Group Scarring

Scarring

United Kingdom
Renovo

Unknown

Adaprev in Digital Flexor Tendon Repair

Tendon Injuries

United Kingdom
Renovo

Completed

Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing

Cicatrix | Wound-healing

United Kingdom
Renovo

Completed

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects

Cicatrix | Re-epithelialisation

United Kingdom
Renovo

Completed

Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times

Cicatrix | Wound-healing

United Kingdom
Renovo

Completed

Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.

Cicatrix

United Kingdom
Renovo

Unknown

Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.

Cicatrix

United Kingdom
Ricardo Rendon

Terminated

The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy

Kidney Neoplasms

Canada
Renova Therapeutics

Withdrawn

AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure (FLOURISH)

Heart Failure
Renovo Concepts, Inc.

Not yet recruiting

A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR™) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.

Clinical Need for Craniotomy or Craniectomy
Tenon Medical

Recruiting

Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System

Sacroiliac Joint Disruption | Degenerative Sacroiliitis

United States
Tenon Medical

Enrolling by invitation

Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan Study

Sacroiliac Joint Disruption | Degenerative Sacroiliitis

United States
Renew Medical

Completed

A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage (REST)

Bowel Incontinence

United States
Xenon Pharmaceuticals Inc.
Novotech Health Holdings Pte. Ltd.

Active, not recruiting

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy (X-TOLE)

Focal Epilepsy

Spain, United States, Ukraine, Canada, United Kingdom, Germany, Georgia, Italy, Moldova, Republic of
Renovo
ICON Clinical Research

Completed

Juvista (Avotermin) in Scars Following Varicose Vein Removal

Cicatrix | Varicose Veins

Belgium, United Kingdom, Latvia, Lithuania
Xenon Pharmaceuticals Inc.

Terminated

XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy (EPIK)

Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Epilepsy | Epileptic Syndromes | Disease | Epilepsy; Seizure | Epilepsy in Children

United States, Spain, Australia, Belgium, Italy
Xenon Pharmaceuticals Inc.

Completed

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.

Healthy Volunteers

United Kingdom
Xenon Pharmaceuticals Inc.

Completed

Single-dose Mass Balance Recovery and Metabolite Profile and Identification of 14C-XEN1101

Healthy Volunteers

United Kingdom
Xenon Pharmaceuticals Inc.

Completed

A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN) (XEN402)

Postherpetic Neuralgia

United States
Xenon Pharmaceuticals Inc.

Completed

Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction

Dental Pain

United States
Renzo Loyaga Rendon
Spectrum Health Hospitals; Van Andel Research Institute

Active, not recruiting

ECMO: Optimization of Its Use

Extracorporeal Membrane Oxygenation Complication

United States
Xenon Pharmaceuticals Inc.

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder (X-NOVA)

Major Depressive Disorder

United States
Xenon Pharmaceuticals Inc.

Completed

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Acne Vulgaris

Canada

3

Subscribe